Resources
About Us
Home Report
Store
Antimicrobial Susceptibility Testing Market
Antimicrobial Susceptibility Testing Market Size, Share, Forecast, & Trends Analysis by Product (Susceptibility Disks, Plates, MIC Strip) Test Type (Antibacterial, Antifungal) Method (Diffusion, Automated) Application End User - Global Forecast to 2031
Report ID:MRHC - 104363 Pages: 182 May-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe Antimicrobial Susceptibility Testing Market was valued at $4.29 billion in 2023. This market is expected to reach $7.21 billion by 2031, from an estimated $4.58 billion in 2024, at a CAGR of 6.7% during the forecast period 2024-2031.
Antimicrobial Susceptibility Testing Market Size & Forecast
The growth of this market is attributed to the high prevalence of infectious diseases, government initiatives and funding toward antimicrobial susceptibility testing programs, technological advancements in the development of new AST methods, and the emergence of multidrug resistance in microorganisms. Moreover, emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer growth opportunities for the players operating in this market.
Antimicrobial Susceptibility Testing Market Growth Drivers
Government Initiatives to Tackle Antimicrobial Susceptibility Testing
Governments worldwide are focused on developing policies and strategies to combat antimicrobial resistance and drive research for the development of new antimicrobials. Various initiatives are being undertaken to create awareness regarding antimicrobial resistance testing and curb antimicrobial abuse, aiding in educating decision-makers, regulatory agencies, and other end users regarding the prevention of antimicrobial resistance.
For instance, in October 2020, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020–2025, was introduced to improve the health and well-being of all Americans by changing the course of antibiotic resistance. This plan prioritizes infection prevention and control to slow the spread of resistant infections and optimize antibiotic use.
Government initiatives for combating multidrug resistance are expected to boost the need for antimicrobial susceptibility testing products, thereby driving the growth of the global antimicrobial susceptibility testing market.
Click here to: Get Free Sample Pages of this Report
High Risk of Bloodstream Infections Globally
Invasion of the bloodstream by microorganisms poses severe health challenges. Bloodstream infections can result in serious consequences like disseminated intravascular coagulation, shock, multiple organ failure, or even death. Common bloodstream infections include sepsis, dengue fever, acquired immunodeficiency syndrome (AIDS), Hepatitis A, Hepatitis B, and Hepatitis C. Common pathogens include Neisseria meningitidis, Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, Salmonella typhi, E. coli, Klebsiella spp, and human immunodeficiency virus (HIV). According to an article published by Vanderbilt University Medical Center in March 2021, mortality rates due to bloodstream infections range between 12% and 32% in North American and European countries.
Sepsis is among the most common types of bloodstream infections and may lead to organ dysfunction. According to WHO statistics updated in August 2020, there were 48.9 million cases of sepsis, with around 11 million sepsis-related deaths globally. Blood culture is the gold standard for diagnosing septicemia. Antibiotics are critical tools for treating life-threatening infections such as sepsis, so the demand for antibiotic sensitivity testing is high in determining the use of the right antimicrobials.
Antimicrobial Susceptibility Testing Market Trends
The Emergence of Multi-drug Resistance
According to the WHO, antimicrobial resistance (AMR) is one of the top 10 global public health threats. The misuse and overuse of antibiotics are major causes of AMR. According to WHO statistics, nearly 700,000 people die each year due to drug-resistant diseases. Drug-resistant diseases are projected to cause 10 million deaths each year by 2050. By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.
R&D for new antimicrobial development has been significantly reduced due to the growing risk of antimicrobial resistance. As of 2021, the World Health Organization (WHO) identified approximately 80 products in the clinical development phase, out of which three are in the pre-registration phase. Furthermore, a lack of access to quality antimicrobials remains a major issue. Antibiotic shortages are affecting healthcare systems in both developed and developing countries, further augmenting the demand for antimicrobial susceptibility testing for antimicrobials and clinical pipeline candidates.
Technological Advancements and New Product Development
The current technologies used for identifying bacterial agents and determining antimicrobial susceptibility are time-consuming and labor-intensive. Therefore, physicians prescribe empirical antimicrobial therapies. This scenario often leads to therapeutic failures, causing higher mortality rates and healthcare costs, as well as the emergence and spread of antibiotic-resistant bacteria. Therefore, new technologies are being developed for the rapid identification of pathogens and antimicrobial susceptibility testing to tackle such scenarios. For instance, in June 2023, Sysmex Corporation (Japan) launched a testing system in Europe for the antimicrobial susceptibility testing of urine samples of patients suspected of suffering from urinary tract infections.
Techniques based on optical imaging, micro-channel resonators, and other biosensors are also emerging due to the increasing clinical demand for various new antimicrobial susceptibility tests. These technological advancements and new product development are driving the adoption of antimicrobial susceptibility testing for bacterial identification and the determination of susceptibility against antimicrobials.
Antimicrobial Susceptibility Testing Market Opportunity
Active Research to Develop Rapid Antimicrobial Susceptibility Testing
The fast emergence of multidrug-resistant microbial pathogens has necessitated a profound understanding of the mechanisms of microbial infections, the development of new diagnostic tools and new antimicrobials. The rationalized use of large-spectrum antimicrobial drugs requires a rapid and sensitive detection system to identify the most appropriate drug against a microorganism.
Current antimicrobial resistance testing (ART) technologies mostly rely on microbial culturing and replication, which can, therefore, take up to 1 to 3 days. Owing to limitations of diagnostic speed, the use of broad-spectrum antimicrobials is preferred over accurate treatment with effective narrow-range antimicrobial agents. Thus, the overuse of broad-spectrum antibiotics accelerates the further rise of AMR worldwide, resulting in active R&D for innovative approaches in development for rapid AST, which aim at faster detection times and reduced sample processing for effortless integration into a clinical lab setting. These include the atomic force microscopy (AFM) cantilever, MALDI-TOF MS and broth dilution, and nano motion detection.
Antimicrobial Susceptibility Testing Market Analysis: Key Findings
By Product: In 2024, the Manual Antimicrobial Susceptibility Testing Products Segment to Dominate the Antimicrobial Susceptibility Testing Market
Based on product, the market is segmented into manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility products, and consumables. In 2024, the manual antimicrobial susceptibility testing segment is expected to account for the largest share of above 52.8% of the antimicrobial susceptibility testing market. Manual antimicrobial susceptibility testing includes susceptibility disks, susceptibility plates, and minimum inhibitory concentration strips. The growing use of antimicrobial susceptibility testing to devise targeted antimicrobial therapy for people and the growing emergence of antibiotic resistance cases are driving the demand for conventional antimicrobial susceptibility testing techniques. High penetration of disk diffusion technique and developments in susceptibility plates are the factors driving manual antimicrobial susceptibility testing and related products market. Furthermore, manual products provide flexibility and allow possible cost savings by using methods like disk diffusion and gradient diffusion methods.
By Method: In 2024, the Disk Diffusion Segment to Dominate the Antimicrobial Susceptibility Testing Market
Based on method, the market is segmented into disk diffusion, automated antimicrobial susceptibility testing, dilution, and other methods. In 2024, the disk diffusion segment is expected to account for the largest share of above 37.6% of the antimicrobial susceptibility testing market. The large share of the segment is attributed to factors such as the test simplicity that does not require any special equipment, the provision of categorical results easily interpreted by all clinicians, and flexibility in the selection of disks for testing. The low cost of performing AST testing with the disk diffusion methods and developments in the method with automated technology are primarily boosting the segment market growth.
However, the automated antimicrobial susceptibility testing segment is expected to grow at the fastest CAGR of above 8.1% during the forecast period of 2024–2031. The use of instrumentation can standardize the reading of endpoints and often produce susceptibility test results in a shorter period than manual readings because sensitive optical detection systems detect subtle changes in bacterial growth. The key factors driving the adoption of automated AST are growing acceptance for automated systems due to relatively accurate and conservative assessment of MICs for most antimicrobials and faster turnaround time of automated AST compared to manual methods.
By Test Type: In 2024, the Antibacterial Tests Segment to Dominate the Antimicrobial Susceptibility Testing Market
Based on test type, the market is segmented into antibacterial tests, anti-parasitic tests, antifungal tests, and other test types. In 2024, the antibacterial tests segment is expected to account for the largest share of the antimicrobial susceptibility testing market. Antibacterial susceptibility tests are procedures that are performed by laboratory professionals to identify an antimicrobial regimen for patients as per their infection type. The large share of the segment is attributed to factors such as higher use of antibacterial tests in clinical diagnosis, growing incidence of bacterial infections, the emergence of antibiotic-resistant bacteria, cost-effectiveness, simplicity, and fast interpretation, ease of use, and availability.
By Application: In 2024, the Clinical Diagnostics Segment to Dominate the Antimicrobial Susceptibility Testing Market
Based on application, the market is segmented into clinical diagnostics, drug discovery and development, and other applications. In 2024, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market. Clinical microbiology detection plays a significant role in the diagnosis of infectious diseases, medication guidance, nosocomial infection control, and antimicrobial management. It helps in the evaluation of treatment services provided by healthcare centers. The large share of the segment is attributed to factors such as the rising burden of antibiotic resistance, increasing incidence of HAIs, the growing procedural volume of clinical diagnostic tests, rising emphasis on effective and early disease diagnosis across major markets, and growing awareness among physicians about antimicrobial susceptibility testing methods.
By End User: The Diagnostic Laboratories and Hospitals Segment to Dominate the Antimicrobial Susceptibility Testing Market
Based on end user, the market is segmented into diagnostic laboratories and hospitals, pharmaceutical and biotechnology companies, and research and academic institutes. In 2024, the diagnostic laboratories and hospitals segment is expected to account for the largest share of the market. The increasing prevalence of infectious diseases and the emergence of microbial resistance against existing antimicrobial treatment options are compelling clinicians to perform AST at hospitals and diagnostic labs. The large share of the segment is attributed to the availability of well-equipped facilities and trained/skilled technicians, the rise in hospital-acquired infections, and initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.
Geographical Analysis
By Geography: North America Region to Dominate the Antimicrobial Susceptibility Testing Market
In 2024, North America is expected to account for the largest share of above 43.9% of the antimicrobial susceptibility testing market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The largest share of the segment is primarily due to the presence of leading manufacturers, large R&D investments, support from government and regulatory authorities, rising antibiotic resistance, and increasing government initiatives to fight antibiotic resistance. According to the CDC, antimicrobial resistance is one of the biggest public health challenges in the U.S. The annual incidence of antibiotic resistance in the U.S. was 2.8 million, with over 35,000 associated deaths. Drug-resistant Candida species are commonly detected among in-patients. As per the same report, nearly 7% of bloodstream infections due to Candida species are resistant to antifungals. Common yeast infections caused by Candida species result in over 3.6 million U.S. healthcare visits annually, with a direct medical cost of USD 3 billion.
However, Asia-Pacific is slated to register the fastest CAGR of above 8.8% during the forecast period. The growing consumption of antibiotics, high prevalence of bloodstream infections, rising incidence of HIV/AIDS, and growing antimicrobial resistance drive the demand for antimicrobial susceptibility testing in the region. Further, the growing focus of government policies on combating antimicrobial resistance also supports the growth of this market.
Antimicrobial Susceptibility Testing Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last three to four years. Some of the key players operating in the antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
As of 2023, Thermo Fisher Scientific, Inc. (U.S.), bioMérieux S.A (France), and Danaher Corporation (U.S.) collectively hold a share of 60%-65% in the global antimicrobial susceptibility testing market.
Antimicrobial Susceptibility Testing Industry Overview: Latest Developments from Key Industry Players
- In February 2023, bioMérieux S.A. (France) launched MAESTRIA, which is microbiology middleware that manages specimens from the moment they are logged into the laboratory workflow.
- In July 2021, Accelerate Diagnostics, Inc. (U.S.) announced the launch of its new IVD configuration of its Accelerate PhenoTest BC Kit in the U.S., which provides fast antimicrobial susceptibility testing (AST) results in approximately 7 hours.
- In April 2021, Becton, Dickinson, and Company (U.S.) launched the BD MAX Molecular Multi-Drug Resistant Tuberculosis (MDR-TB) Assay that is used for the high diagnostic accuracy testing for tuberculosis and is recognized by the World Health Organization (WHO).
Antimicrobial Susceptibility Testing Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
182 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
6.7% |
|
Market Size (Value) |
USD 7.21 Billion by 2031 |
|
Segments Covered |
By Product
By Method
By Test Type
By Application
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
|
Key Companies |
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China) |
Key questions answered in the antimicrobial susceptibility testing market report:
This market study covers the market sizes and forecasts of antimicrobial susceptibility testing based on product, method, test type, application, end user, and geography. It also provides the value analysis of various segments and sub-segments of the global antimicrobial susceptibility testing market at country levels.
The antimicrobial susceptibility testing market is projected to reach $7.21 billion by 2031, at a CAGR of 6.7% during the forecast period.
The manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the market in 2024. The growing use of antimicrobial susceptibility testing to devise targeted antimicrobial therapy for patients and the growing emergence of antibiotic resistance cases are the factors driving the demand for conventional antimicrobial susceptibility testing techniques. The high penetration of the disk diffusion technique and developments in susceptibility plates are driving the manual antimicrobial susceptibility testing and related products market.
Among methods, the automated antimicrobial susceptibility testing segment is slated to register the highest CAGR in the market. The segment's fast growth is attributed to the growing acceptance of automated systems, which are relatively accurate and conservative in assessing minimum inhibitory concentrations for most antimicrobials.
The growth of the antimicrobial susceptibility testing market is driven by the high prevalence of infectious diseases, increasing government initiatives and funding towards antimicrobial susceptibility testing programs, technological advancements towards the development of new AST methods, and the emergence of multidrug resistance in microorganisms. Moreover, emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer growth opportunities for the players operating in the antimicrobial susceptibility testing market.
The key players profiled in the antimicrobial susceptibility testing market report are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
Countries such as China, Brazil, and India are expected to offer significant growth opportunities for the vendors in this market during the analysis period. This is due to factors such as collaborative efforts by the government, health authorities, and medical professionals to combat antimicrobial resistance, the high consumption of antibiotics, the growing issues associated with MRSA, and the high incidence of sepsis and HIV/AIDS that drive antibiotic susceptibility testing in China.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. High Prevalence of Infectious Diseases
4.2.2. Development of Automated and Manual AST Products
4.2.3. Increased Funding and Government Initiatives
4.3. Restraint
4.3.1. Stringent Government Regulations
4.4. Opportunities
4.4.1. Active R&D to Develop Rapid Antimicrobial Susceptibility Testing
4.4.2. Emerging Markets
4.5. Challenges
4.5.1. High Cost of Automated Antimicrobial Susceptibility Testing
4.5.2. Issues in AMR Surveillance in Low-income and Middle-income Countries
4.6. Trends
4.6.1. Emergence of Multidrug Resistance
4.6.2. Technological Advancements and New Product Development
4.7. Regulatory Analysis
4.8. Pricing Analysis
4.9. Porter’s Five Force Analysis
5. Antimicrobial Susceptibility Testing Market—by Product
5.1. Overview
5.2. Manual Antimicrobial Susceptibility Testing Products
5.2.1. Susceptibility Disks
5.2.2. Susceptibility Plates
5.2.3. Minimum Inhibitory Concentration (MIC) Strips
5.3. Automated Antimicrobial Susceptibility Testing Products
5.4. Consumables
6. Antimicrobial Susceptibility Market—by Method
6.1. Overview
6.2. Disk Diffusion
6.3. Automated Antimicrobial Susceptibility Testing
6.4. Dilution
6.5. Other Methods
7. Antimicrobial Susceptibility Testing Market—by Test Type
7.1. Overview
7.2. Antibacterial Tests
7.3. Anti-parasitic Tests
7.4. Antifungal Tests
7.5. Other Test Types
8. Antimicrobial Susceptibility Testing Market—by Application
8.1. Overview
8.2. Clinical Diagnostics
8.3. Drug Discovery and Development
8.4. Other Applications
9. Antimicrobial Susceptibility Testing Market—by End User
9.1. Overview
9.2. Diagnostic Laboratories & Hospitals
9.3. Pharmaceutical & Biotechnology Companies
9.4. Research & Academic Institutes
10. Antimicrobial Susceptibility Testing Market—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. U.K.
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Switzerland
10.3.7. Denmark
10.3.8. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa
11. Competitive Analysis
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Market Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/ Market Ranking, by Key Players (2023)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Danaher Corporation
12.2. Becton, Dickinson And Company
12.3. Bio-Rad Laboratories, Inc.
12.4. Thermo Fisher Scientific Inc.
12.5. HiMedia Laboratories Pvt. Ltd.
12.6. Merlin Diagnostika GmbH
12.7. bioMérieux S.A
12.8. Merck KGaA
12.9. Accelerate Diagnostics, Inc.
12.10. Alifax S.r.l.
12.11. Creative Diagnostics
12.12. Synbiosis
12.13. Zhuhai Dl Biotech Co., Ltd.
(Note: SWOT analysis for the top 5 players will be provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 2 Global Manual Antimicrobial Susceptibility Testing Products Market, by Type, 2022–2031 (USD Million)
Table 3 Global Manual Antimicrobial Susceptibility Testing Products Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Key Companies Offering Susceptibility Disks
Table 5 Global Susceptibility Disks Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Key Companies Offering Susceptibility Plates
Table 7 Global Susceptibility Plates Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Key Companies Offering MIC Strips
Table 9 Global MIC Strips Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Key Companies Offering AST Consumables
Table 11 Global Antimicrobial Susceptibility Testing Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Key Companies Offering Automated AST Products
Table 13 Global Automated Antimicrobial Susceptibility Testing Products Market, by Country/Region, 2022 –2031 (USD Million)
Table 14 Global Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 15 Comparative Features of Diffusion and Dilution Methods
Table 16 Testing Time for Antimicrobial Susceptibility Testing Methods
Table 17 Global Antimicrobial Susceptibility Testing Market for Disk Diffusion, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Antimicrobial Susceptibility Testing Market for Automated Antimicrobial Susceptibility Testing, by Country/Region, 2022– 2031 (USD Million)
Table 19 Comparative Features of Dilution Methods
Table 20 Global Antimicrobial Susceptibility Testing Market for Dilution, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Antimicrobial Susceptibility Testing Market for Other Methods, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 23 Global Antibacterial Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Anti-parasitic Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Antifungal Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Antimicrobial Susceptibility Testing Market for Other Test Types, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 28 Global Antimicrobial Susceptibility Testing Market for Clinical Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Antimicrobial Susceptibility Testing Market for Drug Discovery and Development, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Antimicrobial Susceptibility Testing Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 32 Global Antimicrobial Susceptibility Testing Market for Diagnostic Laboratories & Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Antimicrobial Susceptibility Testing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Antimicrobial Susceptibility Testing Market for Research and Academic Institutes, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Antimicrobial Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 36 North America: Antimicrobial Susceptibility Testing Market, by Country, 2022–2031 (USD Million)
Table 37 North America: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 38 North America: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 39 North America: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 40 North America: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 41 North America: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 42 North America: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 43 U.S.: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 44 U.S.: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 45 U.S.: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 46 U.S.: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 47 U.S.: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 48 U.S.: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 49 Canada: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 50 Canada: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 51 Canada: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 52 Canada: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 53 Canada: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 54 Canada: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 55 Initiatives for Antimicrobial Resistance in Europe
Table 56 Europe: Antimicrobial Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 57 Europe: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 58 Europe: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 59 Europe: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 60 Europe: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 61 Europe: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 62 Europe: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 63 Germany: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 64 Germany: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 65 Germany: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 66 Germany: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 67 Germany: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 68 Germany: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 69 U.K.: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 70 U.K.: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 71 U.K.: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 72 U.K.: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 73 U.K.: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 74 U.K.: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 75 France: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 76 France: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 77 France: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 78 France: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 79 France: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 80 France: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 81 Italy: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 82 Italy: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 83 Italy: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 84 Italy: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 85 Italy: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 86 Italy: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 87 Spain: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 88 Spain: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 89 Spain: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 90 Spain: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 91 Spain: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 92 Spain: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 93 Switzerland: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 94 Switzerland: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 95 Switzerland: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 96 Switzerland: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 97 Switzerland: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 98 Switzerland: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 99 Denmark: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 100 Denmark: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 101 Denmark: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 102 Denmark: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 103 Denmark: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 104 Denmark: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 105 Rest of Europe: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 106 Rest of Europe: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 107 Rest of Europe: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 108 Rest of Europe: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 109 Rest of Europe: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 110 Rest of Europe: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 111 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 112 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 113 Asia-Pacific: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 114 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 115 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 116 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 117 Asia-Pacific: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 118 China: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 119 China: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 120 China: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 121 China: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 122 China: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 123 China: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 124 Japan: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 125 Japan: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 126 Japan: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 127 Japan: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 128 Japan: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 129 Japan: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 130 India: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 131 India: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 132 India: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 133 India: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 134 India: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 135 India: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 136 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 137 Rest of Asia-Pacific: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 138 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 139 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 140 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 141 Rest of Asia-Pacific: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 142 Latin America: Antimicrobial Susceptibility Testing Market, by Country/Region, 2022–2031 (USD Million)
Table 143 Latin America: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 144 Latin America: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 145 Latin America: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 146 Latin America: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 147 Latin America: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 148 Latin America: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 149 Brazil: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 150 Brazil: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 151 Brazil: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 152 Brazil: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 153 Brazil: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 154 Brazil: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 155 Mexico: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 156 Mexico: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 157 Mexico: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 158 Mexico: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 159 Mexico: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 160 Mexico: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 161 Rest of Latin America: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 162 Rest of Latin America: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 163 Rest of Latin America: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 164 Rest of Latin America: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 165 Rest of Latin America: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 166 Rest of Latin America: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 167 Middle East & Africa: Antimicrobial Susceptibility Testing Market, by Product, 2022–2031 (USD Million)
Table 168 Middle East & Africa: Manual Antimicrobial Susceptibility Testing Market, by Type, 2022–2031 (USD Million)
Table 169 Middle East & Africa: Antimicrobial Susceptibility Testing Market, by Method, 2022–2031 (USD Million)
Table 170 Middle East & Africa: Antimicrobial Susceptibility Testing Market, by Test Type, 2022–2031 (USD Million)
Table 171 Middle East & Africa: Antimicrobial Susceptibility Testing Market, by Application, 2022–2031 (USD Million)
Table 172 Middle East & Africa: Antimicrobial Susceptibility Testing Market, by End User, 2022–2031 (USD Million)
Table 173 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Antimicrobial Susceptibility Testing Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 Global Antimicrobial Susceptibility Testing Market, by Method, 2024 Vs. 2031 (USD Million)
Figure 9 Global Antimicrobial Susceptibility Testing Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 10 Global Antimicrobial Susceptibility Testing Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 Global Antimicrobial Susceptibility Testing Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 12 Antimicrobial Susceptibility Testing Market, by Geography
Figure 13 Global Antimicrobial Susceptibility Testing Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 14 Global Antimicrobial Susceptibility Testing Market, by Method, 2024 Vs. 2031 (USD Million)
Figure 15 Global Antimicrobial Susceptibility Testing Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 16 Global Antimicrobial Susceptibility Testing Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 17 Global Antimicrobial Susceptibility Testing Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 18 List of New Molecular Entity Approvals (NME) Per Year
Figure 19 Global Antimicrobial Susceptibility Testing Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 20 North America: Antimicrobial Susceptibility Testing Market Snapshot
Figure 21 U.S.: Candida Bloodstream Infections, by Species
Figure 22 Cases of Drug-resistant Candida in Hospitalized Patients in the U.S.
Figure 23 Europe: Antimicrobial Susceptibility Testing Market Snapshot
Figure 24 Italy: Deaths by Antimicrobial Resistance (2015–2050)
Figure 25 Asia-Pacific: Antimicrobial Susceptibility Testing Market Snapshot
Figure 26 Latin America: Antimicrobial Susceptibility Testing Market Snapshot
Figure 27 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 28 Antimicrobial Susceptibility Testing Market: Competitive Benchmarking (Based On Product)
Figure 29 Global Antimicrobial Susceptibility Testing Market: Competitive Benchmarking, by Product
Figure 30 Global Antimicrobial Susceptibility Testing Market: Competitive Dashboard
Figure 31 Global Antimicrobial Susceptibility Testing Market: Market Share Analysis/Market Ranking (2023)
Figure 32 Bio-Rad Laboratories, Inc.: Financial Overview (2023)
Figure 33 Thermo Fisher Scientific Inc: Financial Overview (2023)
Figure 34 Bruker Corporation: Financial Overview (2023)
Figure 35 bioMérieux S.A: Financial Overview (2023)
Figure 36 Merck KGaA: Financial Overview (2023)
Figure 37 Accelerate Diagnostics, Inc.: Financial Overview (2023)
Figure 38 SDI Group plc: Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Antimicrobial Coatings Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
Europe DTC Laboratory Testing Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Microbiology Testing Market - Global Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jun-2024
Genetic Testing Market - Global Opportunity Analysis And Industry Forecast (2023-2030)
Published Date: Apr-2023
